Company Filing History:
Years Active: 2022
Title: Thomas Mueller: Innovator in Pharmaceutical Compositions
Introduction
Thomas Mueller is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). His innovative work has led to the development of a unique solid pharmaceutical composition.
Latest Patents
Thomas Mueller holds a patent for solid pharmaceutical compositions designed for treating HCV. The invention features a formulation that includes two compounds, specifically Compound 1 and Compound 2. The solid pharmaceutical composition consists of a first layer containing 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a surfactant, all formulated in an amorphous solid dispersion. Additionally, the second layer comprises 40 mg of Compound 2, also combined with a hydrophilic polymer and surfactant in an amorphous solid dispersion.
Career Highlights
Throughout his career, Thomas Mueller has worked with prominent companies in the pharmaceutical industry. He has been associated with AbbVie Inc. and Merck Patent GmbH, where he has contributed to various innovative projects and research initiatives.
Collaborations
Some of his notable coworkers include Nancy E. Sever and Ulrich Westedt. Their collaboration has likely played a role in advancing the research and development of pharmaceutical solutions.
Conclusion
Thomas Mueller's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the treatment of HCV. His work continues to impact the field positively, showcasing the importance of research and development in healthcare.